
FILE PHOTO: A man walks out of the Bombay Stock Exchange (BSE) building in Mumbai, India, February 28, 2020. REUTERS/Hemanshi Kamani/File Photo | Photo Credit: HEMANSHI KAMANI
Krsnaa Diagnostics listed with 7 per cent premium in the bourses on Monday, against the issue price of ₹954.
In the BSE, the company opened at ₹1,025.00, with ₹71.00 or 7.44 per cent gains over the issue price.
After reaching a high of ₹1,028.90, it was trading at ₹1,027.50, up ₹73.50 or 7.70 per cent against the issue price at 10.01 am.
On the NSE, it opened at ₹1,005.5. It was trading at ₹1,041.30, up ₹87.30 or 9.15 per cent against the issue price.
Krsnaa Diagnostics’ public issue, which comprises a fresh issue of ₹400 crore and an offer for sale of up to 85.25 lakh shares by existing selling shareholders, was subscribed so far by 64.38 times. Krsnaa Diagnostics fixed the IPO price at ₹954, the upper end of the price band of ₹933-954. Through the IPO, it had raised ₹1,214. crore.
The portion reserved for retail investors was subscribed almost 42 times while HNIs portion received bids for 116.30 times. Quota for QIB received bids for almost 50 times while employee portion managed to receive its full quota.
The company had raised ₹537 crore from anchor investors by allotting 56.29 shares at a price of ₹954 a share.
Published on August 16, 2021
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.